IMRX
Immuneering Corp
0.00 (0.00%)4.45USD203K成交股數115M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| 毛利 | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 14.0M | 10.6M | 10.9M | 10.5M | 11.5M | 14.9M | 11.3M | 10.7M | 11.2M | 10.1M | 9.5M | 10.2M |
| 銷售管理費用 | 5.0M | 4.7M | 4.5M | 4.3M | 4.0M | 3.7M | 4.0M | 4.3M | 4.1M | 3.9M | 4.0M | 4.5M |
| 營業利益 | −19.0M+23% | −15.3M-17% | −15.4M+1% | −14.8M-1% | −15.5M+1% | −18.6M+33% | −15.3M+13% | −14.9M+2% | −15.3M | −13.9M | −13.5M | −14.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −17.3M+15% | −13.5M-25% | −15.0M+3% | −14.4M+3% | −15.0M+5% | −18.1M+43% | −14.6M+20% | −14.1M+3% | −14.3M | −12.6M | −12.2M | −13.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.27-36% | -0.21-64% | -0.38-22% | -0.40-15% | -0.42-14% | -0.59+37% | -0.49+14% | -0.47-8% | -0.49 | -0.43 | -0.43 | -0.51 |
| 稀釋股數 | 64.7M | 64.7M | 39.7M | 36.0M | 35.5M | 30.0M | 29.8M | 29.7M | 29.4M | 29.3M | 28.6M | 26.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 41.3M | 47.3M | 228M | 26.4M | 35.9M | 36.1M | 45.2M | 59.7M | 66.3M | 68.0M | 104M | 77.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 1K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 202M | 215M | 241M | 40.1M | 50.7M | 52.7M | 68.6M | 77.1M | 88.0M | 114M | 125M | 108M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 11.3M | 8.3M | 13.1M | 11.1M | 8.8M | 11.3M | 10.8M | 10.8M | 9.3M | 9.9M | 9.8M | 9.9M |
| 股東權益 | 191M | 207M | 228M | 28.9M | 41.8M | 41.4M | 57.7M | 66.3M | 78.7M | 104M | 115M | 97.8M |
| 負債比 | 5.6% | 3.9% | 5.4% | 27.8% | 17.4% | 21.5% | 15.8% | 14.0% | 10.5% | 8.7% | 7.8% | 9.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −18.4M | – | – | −14.1M-9% | – | – | – | −15.5M | – | – | −14.4M |
| 資本支出 | – | 80K | – | – | 9K | – | – | – | 37K | – | – | 28K |
| 自由現金流 | – | −18.5M | – | – | −14.1M-9% | – | – | – | −15.5M | – | – | −14.4M |
| 折舊攤銷 | 84K | 81K | 79K | 85K | 85K | 86K | 89K | 91K | 90K | 78K | 78K | 77K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −56.0M | –% | -1.27 | −45.5M |
| FY2024 | – | – | −61.0M | –% | -2.04 | −55.1M |
| FY2023 | 0.00 | -100.0% | −53.5M | –% | -1.88 | −49.3M |
| FY2022 | 317K | -84.8% | −50.5M | -15,937.3% | -1.91 | −44.8M |
| FY2021 | 2.1M | -10.0% | −33.5M | -1,612.3% | -2.46 | −30.9M |
| FY2020 | 2.3M | – | −17.0M | -737.2% | -3.44 | −14.7M |